Cornercap Investment Counsel Inc Harmony Biosciences Holdings, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 17,515 shares of HRMY stock, worth $541,038. This represents 0.09% of its overall portfolio holdings.
Number of Shares
17,515
Previous 17,515
-0.0%
Holding current value
$541,038
Previous $565,000
4.07%
% of portfolio
0.09%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$347 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$183 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$112 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$80.5 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$77.1 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.83B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...